Praetorian update: As expected, aresa will convene a general meeting, to raise new capital.

The independent analysis provider, Praetorian Research has published their
latest update regarding aresa, and states: 

As expected, aresa will convene a general meeting, now scheduled for 17 
september, to raise new capital. The company strikes a downbeat tone regarding
the business potential of the landmine plant, and we see this as a first
indication that part of the investment case may die away. aresa plans to
enhance its focus on acquisition of mine contaminated agricultural land; the
purpose of the new capital. 

For more information, please contact Jesper Ilsøe, Praetorian Research, tlf:
5025 3000, email: info@p-research.dk 

or                                                                              

Steen Thaarup                                                                   
CEO                                                                             

Phone: +45 7022 7747                                                            
Mobile: +45 4077 8695                                                           
E-mail: st@aresa.dk                                                             

The company's certified advisor is Dahl-Sørensen & Partners A/S, Allan Reimann, 
tel.: +45 3364 9205.                                                            


About Aresa                                                                     
Aresa is a plant biotech company established in 2001 by the company's current   
CSO, Carsten Meier. It originates from the Institute of Molecular Biology at    
Copenhagen University.                                                          

Aresa focuses on the plant-based technology platform: BioSensor for the         
detection of substances in soil, including leakage of explosives from landmines.

Aresa shares are traded at the Nasdaq/OMX-First North stock exchange since the  
introduction in 2006. Aresa is based at Symbion Science Park in Copenhagen and  
has greenhouse facilities on the outskirts of Copenhagen and test sites in      
Denmark, Croatia, and Serbia. Aresa has 11 employees, 7 in research &           
development and 2 in landmine operations.